About Us
Guangzhou Raydose Medical Technology Co., Ltd.
Guangzhou Raydose Medical Technology Co., Ltd. was founded in 2012 as an innovative technology company specializing in radiotherapy. Since our inception, we have not only provided high-quality products and technical services to hundreds of radiation therapy units but also continuously expanded our business scope. We have independently developed and established a comprehensive radiation therapy QA product line, including Machine QA, Patient QA, and Radioprotection.
Over the past decade, Raydose has been dedicated to innovation and R&D,committed to providing users with professional and efficient radiotherapy QA product solutions. in the future, we will continue to delve into the QA field, continuously innovating in areas such as new technology QA and radiation protection, injecting impetus into the industry's development.
13+
Since founded
17+
Products
46+
Patents
500+
Clients
Development History
2025
AutoScanner(AS600)
2024
MQC
2023
MC-Plus
2020
AD-II
2019
ArcMap
2018
AtuoScanner(AS450)
2017
FilmDose
2015
MC-III
2013
EDose
Milestones
2025
2024
2023
2020
2019
2018
2017
2015
2013
Our Services
We offer comprehensive support services, including after-sales assistance, product trials, and collaboration opportunities, sincerely dedicated to providing you with the best solutions.
Tailored Support and Service for You
Professional service team on standby 24/7
Professional After-Sales Support
Raydose is backed by an experienced after-sales service team, providing fast response and precise technical support to ensure the stable operation of device, empowering clients to carry out their work efficiently.
Product Trial Service
We offer product trial services, allowing clients to fully validate device performance in real clinical environments. This helps clients gain a comprehensive understanding of our products' features and application outcomes, and experience the outstanding quality we deliver.
Collaborative R&D and Technical Exchange
Raydose welcomes in-depth collaboration and exchanges with academic institutions, healthcare providers, and industry partners. We support joint research and development initiatives, working together to drive innovation in radiotherapy.
Contact Us